Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON29662Phase 3Active, not recruiting
Phase 3, open-label trial of remifentanil, ropivacaine and sufentanil in labor pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Maternal temperature and Maternal oxygen saturation. Started Dec 2008; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON29662.